Lindbrook Capital LLC Acquires 738 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Lindbrook Capital LLC raised its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 52.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,141 shares of the company’s stock after purchasing an additional 738 shares during the period. Lindbrook Capital LLC’s holdings in GE HealthCare Technologies were worth $166,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in GEHC. First Command Advisory Services Inc. grew its holdings in shares of GE HealthCare Technologies by 36,900.0% during the third quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock valued at $25,000 after buying an additional 369 shares during the last quarter. Fortitude Family Office LLC purchased a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $29,000. Legacy Financial Group LLC purchased a new stake in shares of GE HealthCare Technologies during the third quarter valued at approximately $26,000. Turtle Creek Wealth Advisors LLC purchased a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $30,000. Finally, OFI Invest Asset Management purchased a new stake in shares of GE HealthCare Technologies during the third quarter valued at approximately $26,000. Institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on GEHC shares. HSBC started coverage on shares of GE HealthCare Technologies in a report on Thursday, February 15th. They issued a “buy” rating and a $100.00 target price on the stock. Mizuho raised their target price on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, April 11th. UBS Group upgraded shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and raised their target price for the stock from $66.00 to $88.00 in a report on Monday, February 12th. Citigroup raised their target price on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. Finally, Morgan Stanley raised their target price on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a report on Monday, February 12th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $95.09.

GE HealthCare Technologies Trading Up 2.3 %

Shares of GE HealthCare Technologies stock opened at $86.24 on Wednesday. The company’s fifty day simple moving average is $88.84 and its 200-day simple moving average is $78.21. The stock has a market capitalization of $39.35 billion, a PE ratio of 28.56, a P/E/G ratio of 2.93 and a beta of 0.94. GE HealthCare Technologies Inc. has a 1-year low of $62.35 and a 1-year high of $94.50. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.05 and a quick ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.11. The business had revenue of $5.20 billion for the quarter, compared to analysts’ expectations of $5.09 billion. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The company’s revenue was up 5.3% compared to the same quarter last year. During the same quarter last year, the company posted $1.31 EPS. As a group, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be given a dividend of $0.03 per share. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. GE HealthCare Technologies’s payout ratio is 3.97%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.